All Sauce from Weekly Sauce:

Coronavirus infections before or after vaccination provide equal levels of increased immunity, and the key to this so-called “super immunity” is to be vaccinated, researchers report. “It makes no difference whether you get infected-and-then-vaccinated, or if you get vaccinated-and-then-a-breakthrough infection,” said study co-senior author Fikadu Tafesse. He is an assistant professor of molecular microbiology and…  read on >  read on >

Support from family and friends, along with exercise and sufficient sleep, have helped protect teens’ mental health during the pandemic, new research shows. The study also found that teen girls have been more likely than boys to suffer mental distress during the pandemic. For the study, researchers analyzed data gathered from more than 3,000 participants,…  read on >  read on >

If you’re wondering whether to intentionally expose yourself to the Omicron variant with the goal of developing immunity, the answer is absolutely not, experts say. “It sounds like playing with fire to me,” said Dr. Nicole Van Groningen, a hospitalist who has treated hundreds of COVID-19 patients at Cedars-Sinai in Los Angeles. First of all,…  read on >  read on >

When older people cut back on physical activity, their risk of type 2 diabetes rises. But walking regularly can help, a new study suggests. The more steps you take — and the more intensely you walk — the lower your odds for type 2 diabetes, researchers found. To assess the link between walking and diabetes…  read on >  read on >

Children in sub-Saharan Africa have a far higher risk of death from COVID-19 than those in the United States and Europe, a new study shows. “Although our study looked at data from earlier in the pandemic, the situation hasn’t changed much for the children of Africa. If anything, it is expected to be worsening with…  read on >  read on >

MONDAY, Jan. 24, 2022 (healthDay News) — The U.S. Food and Drug Administration said Monday that it will curtail the use of two monoclonal antibody treatments that do not appear to work against the highly contagious Omicron variant. The combo treatments bamlanivimab/etesevimab and casirivimab/imdevimab, made by Eli Lilly and Regeneron, respectively, performed well against earlier…  read on >  read on >